# AbbVie Deutschland GmbH & Co. KG – FDA Inspection, Oct 25, 2012

Source: https://www.keypedia.com/records/fda_inspections/abbvie-deutschland-gmbh-co-kg/c17c30a4-104e-4c61-b34e-b5c14c99bc62
Source feed: FDA_Inspections

> FDA inspection 806316 of AbbVie Deutschland GmbH & Co. KG, October 25, 2012. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 806316
- Company Name: AbbVie Deutschland GmbH & Co. KG
- Inspection Date: 2012-10-25
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- FDA Inspection 1272781 - 2025-05-16
- FDA Inspection 1274472 - 2023-09-28
- FDA Inspection 1100574 - 2019-07-19
- FDA Inspection 1018744 - 2017-06-23
- FDA Inspection 900873 - 2014-09-18

Company: https://www.keypedia.com/companies/abbvie-deutschland-gmbh-co-kg/009c9ce8-8fd1-4896-b5f3-ca9f43bc2e9b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
